Alessandra Pescatore

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

A case of Incontinentia Pigmenti associated with concurrent IKBKG/NEMO and MED13L mutations.

A case of Incontinentia Pigmenti associated with concurrent IKBKG/NEMO and MED13L mutations.

Journal: Frontiers in medicine

Published: February 27, 2026

GADD45β inhibits RIPK3-mediated NF-κB activation by interfering with NEMO-RIPK1-RIPK3 interactions.

GADD45β inhibits RIPK3-mediated NF-κB activation by interfering with NEMO-RIPK1-RIPK3 interactions.

Journal: Cell death discovery

Published: May 26, 2025

Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

Journal: The Journal of experimental medicine

Published: July 06, 2023

Ubiquitin Specific Protease USP48 Destabilizes NF-κB/p65 in Retinal Pigment Epithelium Cells.

Ubiquitin Specific Protease USP48 Destabilizes NF-κB/p65 in Retinal Pigment Epithelium Cells.

Journal: International journal of molecular sciences

Published: July 20, 2022

Human Genetic Diseases Linked to the Absence of NEMO: An Obligatory Somatic Mosaic Disorder in Male.

Human Genetic Diseases Linked to the Absence of NEMO: An Obligatory Somatic Mosaic Disorder in Male.

Journal: International journal of molecular sciences

Published: December 20, 2021

Methods to Study the Effect of IKK Inhibition on TNF-Inducing Apoptosis and Necroptosis in Cultured Cells.

Methods to Study the Effect of IKK Inhibition on TNF-Inducing Apoptosis and Necroptosis in Cultured Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 08, 2021

Life, death, and autophagy in cancer: NF-κB turns up everywhere.

Life, death, and autophagy in cancer: NF-κB turns up everywhere.

Journal: Cell death & disease

Published: January 06, 2020

Clinical utility gene card: for incontinentia pigmenti.

Clinical utility gene card: for incontinentia pigmenti.

Journal: European journal of human genetics : EJHG

Published: February 05, 2019

The Incontinentia Pigmenti Genetic Biobank: study design and cohort profile to facilitate research into a rare disease worldwide.

The Incontinentia Pigmenti Genetic Biobank: study design and cohort profile to facilitate research into a rare disease worldwide.

Journal: European journal of human genetics : EJHG

Published: November 07, 2018

The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells.

The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: July 05, 2017

NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II.

NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II.

Journal: Cell death & disease

Published: April 26, 2016

Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.

Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.

Journal: The Journal of allergy and clinical immunology

Published: March 07, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026